COVID-19 Mutant Strain Threat Prompted Covaxin’s Approval, Say Minutes Of SEC Meetings
New Delhi: The impending danger of the new mutant strain of coronavirus found in the UK helped Bharat Biotech get emergency use approval for its vaccine candidate Covaxin. India has ...